

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 8.46957011 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.38729805 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.38729805 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.17461933 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.17461933 |
| 6 | angiotensin maturation (GO:0002003) | 6.92397262 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.82112117 |
| 8 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 6.38727179 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 6.29383457 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 6.29383457 |
| 11 | tryptophan catabolic process (GO:0006569) | 6.29383457 |
| 12 | fat-soluble vitamin biosynthetic process (GO:0042362) | 6.22474955 |
| 13 | drug metabolic process (GO:0017144) | 6.20821787 |
| 14 | glyoxylate metabolic process (GO:0046487) | 6.13029232 |
| 15 | kynurenine metabolic process (GO:0070189) | 5.99835600 |
| 16 | tryptophan metabolic process (GO:0006568) | 5.90791294 |
| 17 | NADH metabolic process (GO:0006734) | 5.85627271 |
| 18 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.81868619 |
| 19 | cysteine metabolic process (GO:0006534) | 5.76197271 |
| 20 | omega-hydroxylase P450 pathway (GO:0097267) | 5.69796141 |
| 21 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.66234433 |
| 22 | bile acid biosynthetic process (GO:0006699) | 5.64807027 |
| 23 | lysine metabolic process (GO:0006553) | 5.46852373 |
| 24 | lysine catabolic process (GO:0006554) | 5.46852373 |
| 25 | alpha-linolenic acid metabolic process (GO:0036109) | 5.33661019 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 5.29978640 |
| 27 | serine family amino acid catabolic process (GO:0009071) | 5.21609249 |
| 28 | urea metabolic process (GO:0019627) | 5.18322820 |
| 29 | urea cycle (GO:0000050) | 5.18322820 |
| 30 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.15811636 |
| 31 | intestinal absorption (GO:0050892) | 5.13481994 |
| 32 | high-density lipoprotein particle remodeling (GO:0034375) | 5.02182001 |
| 33 | hormone catabolic process (GO:0042447) | 5.01717212 |
| 34 | aromatic amino acid family metabolic process (GO:0009072) | 4.97182006 |
| 35 | homocysteine metabolic process (GO:0050667) | 4.85296414 |
| 36 | negative regulation of fibrinolysis (GO:0051918) | 4.83563274 |
| 37 | nitrogen cycle metabolic process (GO:0071941) | 4.80823549 |
| 38 | bile acid metabolic process (GO:0008206) | 4.79536416 |
| 39 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.79058602 |
| 40 | protein carboxylation (GO:0018214) | 4.79058602 |
| 41 | amino-acid betaine metabolic process (GO:0006577) | 4.78837626 |
| 42 | cellular ketone body metabolic process (GO:0046950) | 4.69154250 |
| 43 | complement activation, alternative pathway (GO:0006957) | 4.65399000 |
| 44 | alpha-amino acid catabolic process (GO:1901606) | 4.65134306 |
| 45 | drug transmembrane transport (GO:0006855) | 4.64052667 |
| 46 | regulation of fibrinolysis (GO:0051917) | 4.61390544 |
| 47 | alkaloid metabolic process (GO:0009820) | 4.59722465 |
| 48 | urate metabolic process (GO:0046415) | 4.58342584 |
| 49 | regulation of protein activation cascade (GO:2000257) | 4.58212432 |
| 50 | regulation of triglyceride catabolic process (GO:0010896) | 4.53481790 |
| 51 | regulation of cholesterol esterification (GO:0010872) | 4.52566021 |
| 52 | protein-lipid complex assembly (GO:0065005) | 4.52313751 |
| 53 | lipoprotein transport (GO:0042953) | 4.50639289 |
| 54 | tyrosine metabolic process (GO:0006570) | 4.50108992 |
| 55 | proline metabolic process (GO:0006560) | 4.44900186 |
| 56 | negative regulation of cholesterol transport (GO:0032375) | 4.44396320 |
| 57 | negative regulation of sterol transport (GO:0032372) | 4.44396320 |
| 58 | indolalkylamine metabolic process (GO:0006586) | 4.43977149 |
| 59 | serine family amino acid metabolic process (GO:0009069) | 4.41925185 |
| 60 | drug catabolic process (GO:0042737) | 4.40640689 |
| 61 | reverse cholesterol transport (GO:0043691) | 4.36934577 |
| 62 | cellular amino acid catabolic process (GO:0009063) | 4.35978107 |
| 63 | amine catabolic process (GO:0009310) | 4.34683460 |
| 64 | cellular biogenic amine catabolic process (GO:0042402) | 4.34683460 |
| 65 | glutamate metabolic process (GO:0006536) | 4.32533134 |
| 66 | diacylglycerol metabolic process (GO:0046339) | 4.31534012 |
| 67 | plasma lipoprotein particle remodeling (GO:0034369) | 4.29590453 |
| 68 | protein-lipid complex remodeling (GO:0034368) | 4.29590453 |
| 69 | macromolecular complex remodeling (GO:0034367) | 4.29590453 |
| 70 | regulation of complement activation (GO:0030449) | 4.27811159 |
| 71 | cellular modified amino acid catabolic process (GO:0042219) | 4.27654141 |
| 72 | phospholipid efflux (GO:0033700) | 4.26782669 |
| 73 | acylglycerol homeostasis (GO:0055090) | 4.26532042 |
| 74 | triglyceride homeostasis (GO:0070328) | 4.26532042 |
| 75 | glycine metabolic process (GO:0006544) | 4.25532609 |
| 76 | cellular glucuronidation (GO:0052695) | 4.25344002 |
| 77 | benzene-containing compound metabolic process (GO:0042537) | 4.23618341 |
| 78 | short-chain fatty acid metabolic process (GO:0046459) | 4.21894995 |
| 79 | regulation of guanylate cyclase activity (GO:0031282) | 4.17283757 |
| 80 | coenzyme catabolic process (GO:0009109) | 4.15087562 |
| 81 | bile acid and bile salt transport (GO:0015721) | 4.14706365 |
| 82 | serine family amino acid biosynthetic process (GO:0009070) | 4.13918071 |
| 83 | ethanol oxidation (GO:0006069) | 4.13210844 |
| 84 | plasma lipoprotein particle organization (GO:0071827) | 4.12399464 |
| 85 | ethanol metabolic process (GO:0006067) | 4.10630155 |
| 86 | aldehyde catabolic process (GO:0046185) | 4.06920078 |
| 87 | ketone body metabolic process (GO:1902224) | 4.05535621 |
| 88 | blood coagulation, intrinsic pathway (GO:0007597) | 4.03997331 |
| 89 | phenylpropanoid metabolic process (GO:0009698) | 4.01728602 |
| 90 | glutamine family amino acid biosynthetic process (GO:0009084) | 4.00939564 |
| 91 | lipoprotein metabolic process (GO:0042157) | 3.98784242 |
| 92 | drug transport (GO:0015893) | 3.94224016 |
| 93 | oxidative demethylation (GO:0070989) | 3.92355304 |
| 94 | aspartate family amino acid catabolic process (GO:0009068) | 3.90356935 |
| 95 | plasma lipoprotein particle clearance (GO:0034381) | 3.90306023 |
| 96 | protein-lipid complex subunit organization (GO:0071825) | 3.89913470 |
| 97 | imidazole-containing compound metabolic process (GO:0052803) | 3.89093424 |
| 98 | glucuronate metabolic process (GO:0019585) | 3.88881300 |
| 99 | uronic acid metabolic process (GO:0006063) | 3.88881300 |
| 100 | organic acid catabolic process (GO:0016054) | 3.88136018 |
| 101 | carboxylic acid catabolic process (GO:0046395) | 3.88136018 |
| 102 | complement activation, classical pathway (GO:0006958) | 3.87065400 |
| 103 | acetyl-CoA metabolic process (GO:0006084) | 3.86902335 |
| 104 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.86733251 |
| 105 | fibrinolysis (GO:0042730) | 3.86075395 |
| 106 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.82912675 |
| 107 | 2-oxoglutarate metabolic process (GO:0006103) | 3.81949502 |
| 108 | positive regulation of lipid catabolic process (GO:0050996) | 3.81678192 |
| 109 | arginine metabolic process (GO:0006525) | 3.80911157 |
| 110 | exogenous drug catabolic process (GO:0042738) | 3.80660811 |
| 111 | * fructose metabolic process (GO:0006000) | 3.74733870 |
| 112 | cholesterol efflux (GO:0033344) | 3.74374484 |
| 113 | flavonoid metabolic process (GO:0009812) | 3.73046000 |
| 114 | negative regulation of blood coagulation (GO:0030195) | 3.72643198 |
| 115 | negative regulation of hemostasis (GO:1900047) | 3.72643198 |
| 116 | fatty acid beta-oxidation (GO:0006635) | 3.72513260 |
| 117 | fatty acid oxidation (GO:0019395) | 3.71437767 |
| 118 | protein activation cascade (GO:0072376) | 3.68460390 |
| 119 | carnitine metabolic process (GO:0009437) | 3.67517384 |
| 120 | vitamin biosynthetic process (GO:0009110) | 3.67061144 |
| 121 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.66453743 |
| 122 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.66453743 |
| 123 | regulation of cholesterol homeostasis (GO:2000188) | 3.65308533 |
| 124 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.64941284 |
| 125 | endocrine process (GO:0050886) | 3.64941284 |
| 126 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.64941284 |
| 127 | plasma lipoprotein particle assembly (GO:0034377) | 3.64671440 |
| 128 | lipid oxidation (GO:0034440) | 3.64237634 |
| 129 | monocarboxylic acid catabolic process (GO:0072329) | 3.63731473 |
| 130 | regulation of bile acid biosynthetic process (GO:0070857) | 3.62196174 |
| 131 | oxaloacetate metabolic process (GO:0006107) | 3.61337522 |
| 132 | valine metabolic process (GO:0006573) | 3.58828640 |
| 133 | complement activation (GO:0006956) | 3.56793021 |
| 134 | cholesterol homeostasis (GO:0042632) | 3.56438901 |
| 135 | acute-phase response (GO:0006953) | 3.55344452 |
| 136 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.55099869 |
| 137 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.55099869 |
| 138 | low-density lipoprotein particle remodeling (GO:0034374) | 3.55080812 |
| 139 | NAD biosynthetic process (GO:0009435) | 3.54829413 |
| 140 | response to nitrosative stress (GO:0051409) | 3.54437165 |
| 141 | heme transport (GO:0015886) | 3.53440490 |
| 142 | renal system process involved in regulation of blood volume (GO:0001977) | 3.52834672 |
| 143 | regulation of plasminogen activation (GO:0010755) | 3.51544814 |
| 144 | proline biosynthetic process (GO:0006561) | 3.51316842 |
| 145 | sterol homeostasis (GO:0055092) | 3.50235666 |
| 146 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.49378366 |
| 147 | intestinal cholesterol absorption (GO:0030299) | 3.41917812 |
| 148 | negative regulation of coagulation (GO:0050819) | 3.41633463 |
| 149 | L-ascorbic acid metabolic process (GO:0019852) | 3.34862380 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.21772226 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.10299380 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.68020900 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.26347590 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.19946827 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.91798259 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.90413623 |
| 8 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.89819392 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.76935947 |
| 10 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.39158201 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.27942003 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.17228150 |
| 13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.05978666 |
| 14 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.04106899 |
| 15 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.5265173 |
| 16 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.67913586 |
| 17 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.57343485 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.54368092 |
| 19 | GATA1_22025678_ChIP-Seq_K562_Human | 1.54144320 |
| 20 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.53021784 |
| 21 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.47796852 |
| 22 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.44220879 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.42580070 |
| 24 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.39464596 |
| 25 | SA1_27219007_Chip-Seq_Bcells_Human | 1.33514283 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.33246031 |
| 27 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.31787303 |
| 28 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.30225341 |
| 29 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.26556395 |
| 30 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.25482588 |
| 31 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.21033874 |
| 32 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.20520676 |
| 33 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.19002741 |
| 34 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.16091169 |
| 35 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14938430 |
| 36 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.13946952 |
| 37 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.13696112 |
| 38 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.10228558 |
| 39 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.09190430 |
| 40 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.08437275 |
| 41 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.08117225 |
| 42 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.06955067 |
| 43 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.04739163 |
| 44 | P68_20966046_ChIP-Seq_HELA_Human | 1.04251168 |
| 45 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.02554331 |
| 46 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.98941186 |
| 47 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.97188512 |
| 48 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.95653402 |
| 49 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.95478408 |
| 50 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.94557628 |
| 51 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.93657432 |
| 52 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.93268553 |
| 53 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.90852632 |
| 54 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.90208154 |
| 55 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.89913980 |
| 56 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89733785 |
| 57 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.89465664 |
| 58 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.87569534 |
| 59 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.87099942 |
| 60 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.86499239 |
| 61 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.84205502 |
| 62 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.83361645 |
| 63 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.83087059 |
| 64 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.81586097 |
| 65 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.81022576 |
| 66 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.81016163 |
| 67 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.80654357 |
| 68 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.79923807 |
| 69 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.79903639 |
| 70 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.79648328 |
| 71 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.79138985 |
| 72 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.79123956 |
| 73 | P300_27268052_Chip-Seq_Bcells_Human | 0.79055787 |
| 74 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.78591659 |
| 75 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.78475446 |
| 76 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77917835 |
| 77 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.77588876 |
| 78 | * SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.77582497 |
| 79 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.77033165 |
| 80 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.76758842 |
| 81 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.76529791 |
| 82 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.76486551 |
| 83 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.76233212 |
| 84 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.76217348 |
| 85 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.76160692 |
| 86 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.75996176 |
| 87 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.75870890 |
| 88 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.75325117 |
| 89 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.75073772 |
| 90 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.74571178 |
| 91 | LDB1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.74543176 |
| 92 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.72144057 |
| 93 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70574306 |
| 94 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.68428364 |
| 95 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66401468 |
| 96 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.65736811 |
| 97 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.64795468 |
| 98 | * PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.63876437 |
| 99 | AR_20517297_ChIP-Seq_VCAP_Human | 0.63056496 |
| 100 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.62205208 |
| 101 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.61212986 |
| 102 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.60845915 |
| 103 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.60238041 |
| 104 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.58569481 |
| 105 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.58051895 |
| 106 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.57518288 |
| 107 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.55257217 |
| 108 | GATA2_19941826_ChIP-Seq_K562_Human | 0.53796748 |
| 109 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.52394310 |
| 110 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.52389095 |
| 111 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.51711622 |
| 112 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.51136385 |
| 113 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.50950985 |
| 114 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.50944735 |
| 115 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.50944735 |
| 116 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.50634779 |
| 117 | GATA1_19941826_ChIP-Seq_K562_Human | 0.49504875 |
| 118 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.48750990 |
| 119 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.48583790 |
| 120 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.48059070 |
| 121 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.47844816 |
| 122 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.47452589 |
| 123 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46958164 |
| 124 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.45192733 |
| 125 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.45179425 |
| 126 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.45115207 |
| 127 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.44812057 |
| 128 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.44612678 |
| 129 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.44415943 |
| 130 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.43188283 |
| 131 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.43181218 |
| 132 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.42598939 |
| 133 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.42484566 |
| 134 | CBP_21632823_ChIP-Seq_H3396_Human | 0.42292255 |
| 135 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.41935516 |
| 136 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.41838165 |
| 137 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.41376815 |
| 138 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.41233545 |
| 139 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.40518087 |
| 140 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.40323949 |
| 141 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.40051673 |
| 142 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.39338750 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.10173239 |
| 2 | MP0005360_urolithiasis | 8.03170318 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.94463117 |
| 4 | MP0005365_abnormal_bile_salt | 5.80179270 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.97892840 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.07683677 |
| 7 | MP0003252_abnormal_bile_duct | 3.75259959 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.30181571 |
| 9 | MP0005332_abnormal_amino_acid | 3.21018447 |
| 10 | MP0009840_abnormal_foam_cell | 3.11000079 |
| 11 | MP0003195_calcinosis | 3.05870596 |
| 12 | MP0005083_abnormal_biliary_tract | 2.70470689 |
| 13 | MP0004019_abnormal_vitamin_homeostasis | 2.67371229 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.65852819 |
| 15 | MP0003183_abnormal_peptide_metabolism | 2.57489108 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.37804543 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 2.24522488 |
| 18 | MP0000609_abnormal_liver_physiology | 2.02327971 |
| 19 | MP0009379_abnormal_foot_pigmentation | 2.00571023 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 1.99986432 |
| 21 | MP0005319_abnormal_enzyme/_coenzyme | 1.86764894 |
| 22 | MP0009643_abnormal_urine_homeostasis | 1.81016531 |
| 23 | MP0001764_abnormal_homeostasis | 1.74329665 |
| 24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.67788098 |
| 25 | MP0003868_abnormal_feces_composition | 1.66696378 |
| 26 | MP0003186_abnormal_redox_activity | 1.51703894 |
| 27 | MP0010155_abnormal_intestine_physiology | 1.45639487 |
| 28 | MP0003879_abnormal_hair_cell | 1.41907267 |
| 29 | MP0005451_abnormal_body_composition | 1.41607236 |
| 30 | MP0005636_abnormal_mineral_homeostasis | 1.39762435 |
| 31 | MP0000678_abnormal_parathyroid_gland | 1.33970863 |
| 32 | MP0009697_abnormal_copulation | 1.31159990 |
| 33 | MP0005409_darkened_coat_color | 1.29027522 |
| 34 | MP0004043_abnormal_pH_regulation | 1.18393274 |
| 35 | MP0003656_abnormal_erythrocyte_physiolo | 1.17965387 |
| 36 | MP0000598_abnormal_liver_morphology | 1.14556254 |
| 37 | MP0003011_delayed_dark_adaptation | 1.13951275 |
| 38 | MP0010234_abnormal_vibrissa_follicle | 1.09047343 |
| 39 | MP0009764_decreased_sensitivity_to | 1.08129239 |
| 40 | MP0001756_abnormal_urination | 1.04892728 |
| 41 | MP0006036_abnormal_mitochondrial_physio | 1.03753116 |
| 42 | MP0005647_abnormal_sex_gland | 0.98257646 |
| 43 | MP0005084_abnormal_gallbladder_morpholo | 0.97627533 |
| 44 | MP0008469_abnormal_protein_level | 0.97450754 |
| 45 | MP0001664_abnormal_digestion | 0.97278140 |
| 46 | MP0002876_abnormal_thyroid_physiology | 0.95914256 |
| 47 | MP0003866_abnormal_defecation | 0.93374494 |
| 48 | MP0009642_abnormal_blood_homeostasis | 0.93079500 |
| 49 | MP0009763_increased_sensitivity_to | 0.92864908 |
| 50 | MP0000604_amyloidosis | 0.92356749 |
| 51 | MP0002136_abnormal_kidney_physiology | 0.91579596 |
| 52 | MP0003705_abnormal_hypodermis_morpholog | 0.87474049 |
| 53 | MP0000490_abnormal_crypts_of | 0.85113852 |
| 54 | MP0005408_hypopigmentation | 0.80333107 |
| 55 | MP0005376_homeostasis/metabolism_phenot | 0.77666880 |
| 56 | MP0001765_abnormal_ion_homeostasis | 0.77431955 |
| 57 | MP0000477_abnormal_intestine_morphology | 0.77296053 |
| 58 | MP0002078_abnormal_glucose_homeostasis | 0.76776154 |
| 59 | MP0009765_abnormal_xenobiotic_induced | 0.75825349 |
| 60 | MP0000566_synostosis | 0.75050035 |
| 61 | MP0005220_abnormal_exocrine_pancreas | 0.74479075 |
| 62 | MP0005535_abnormal_body_temperature | 0.74356375 |
| 63 | MP0002254_reproductive_system_inflammat | 0.73737933 |
| 64 | MP0005670_abnormal_white_adipose | 0.73565373 |
| 65 | MP0010368_abnormal_lymphatic_system | 0.70036871 |
| 66 | MP0005058_abnormal_lysosome_morphology | 0.67836956 |
| 67 | MP0002971_abnormal_brown_adipose | 0.64648305 |
| 68 | MP0005266_abnormal_metabolism | 0.63682381 |
| 69 | MP0005334_abnormal_fat_pad | 0.63388642 |
| 70 | MP0004270_analgesia | 0.63240163 |
| 71 | MP0002249_abnormal_larynx_morphology | 0.62610968 |
| 72 | MP0006035_abnormal_mitochondrial_morpho | 0.61925677 |
| 73 | MP0001661_extended_life_span | 0.60746921 |
| 74 | MP0005464_abnormal_platelet_physiology | 0.60160674 |
| 75 | MP0003724_increased_susceptibility_to | 0.60052419 |
| 76 | MP0003638_abnormal_response/metabolism_ | 0.59344821 |
| 77 | MP0002928_abnormal_bile_duct | 0.58083313 |
| 78 | MP0000462_abnormal_digestive_system | 0.57220387 |
| 79 | MP0004858_abnormal_nervous_system | 0.55175456 |
| 80 | MP0001188_hyperpigmentation | 0.54773473 |
| 81 | MP0003329_amyloid_beta_deposits | 0.52791229 |
| 82 | MP0003690_abnormal_glial_cell | 0.52576658 |
| 83 | MP0001663_abnormal_digestive_system | 0.51026048 |
| 84 | MP0004130_abnormal_muscle_cell | 0.50742082 |
| 85 | MP0002089_abnormal_postnatal_growth/wei | 0.48848730 |
| 86 | MP0010352_gastrointestinal_tract_polyps | 0.48766986 |
| 87 | MP0009053_abnormal_anal_canal | 0.48231363 |
| 88 | MP0004147_increased_porphyrin_level | 0.47892536 |
| 89 | MP0005395_other_phenotype | 0.47606005 |
| 90 | MP0005448_abnormal_energy_balance | 0.47228727 |
| 91 | MP0003436_decreased_susceptibility_to | 0.47183728 |
| 92 | MP0000230_abnormal_systemic_arterial | 0.46745135 |
| 93 | MP0003075_altered_response_to | 0.45718505 |
| 94 | MP0004264_abnormal_extraembryonic_tissu | 0.45381671 |
| 95 | MP0000538_abnormal_urinary_bladder | 0.44938843 |
| 96 | MP0008873_increased_physiological_sensi | 0.44142801 |
| 97 | MP0003953_abnormal_hormone_level | 0.43986484 |
| 98 | MP0009333_abnormal_splenocyte_physiolog | 0.42895227 |
| 99 | MP0005166_decreased_susceptibility_to | 0.42292339 |
| 100 | MP0001501_abnormal_sleep_pattern | 0.41931075 |
| 101 | MP0000639_abnormal_adrenal_gland | 0.41511747 |
| 102 | MP0009785_altered_susceptibility_to | 0.41431318 |
| 103 | MP0001845_abnormal_inflammatory_respons | 0.41017274 |
| 104 | MP0005381_digestive/alimentary_phenotyp | 0.40834833 |
| 105 | MP0008260_abnormal_autophagy | 0.40714595 |
| 106 | MP0008874_decreased_physiological_sensi | 0.40541507 |
| 107 | MP0005666_abnormal_adipose_tissue | 0.40518354 |
| 108 | MP0004782_abnormal_surfactant_physiolog | 0.40246955 |
| 109 | MP0003300_gastrointestinal_ulcer | 0.39783033 |
| 110 | MP0002135_abnormal_kidney_morphology | 0.39772444 |
| 111 | MP0002168_other_aberrant_phenotype | 0.38925550 |
| 112 | MP0006082_CNS_inflammation | 0.38679567 |
| 113 | MP0002796_impaired_skin_barrier | 0.37239157 |
| 114 | MP0003718_maternal_effect | 0.36688448 |
| 115 | MP0001881_abnormal_mammary_gland | 0.36075096 |
| 116 | MP0008872_abnormal_physiological_respon | 0.36064827 |
| 117 | MP0002098_abnormal_vibrissa_morphology | 0.34998488 |
| 118 | MP0002822_catalepsy | 0.34178151 |
| 119 | MP0001853_heart_inflammation | 0.33081222 |
| 120 | MP0001873_stomach_inflammation | 0.31713798 |
| 121 | MP0003315_abnormal_perineum_morphology | 0.30870160 |
| 122 | MP0009115_abnormal_fat_cell | 0.29894125 |
| 123 | MP0002069_abnormal_eating/drinking_beha | 0.29274505 |
| 124 | MP0000249_abnormal_blood_vessel | 0.29165169 |
| 125 | MP0009672_abnormal_birth_weight | 0.28747962 |
| 126 | MP0002837_dystrophic_cardiac_calcinosis | 0.28577910 |
| 127 | MP0002970_abnormal_white_adipose | 0.28157844 |
| 128 | MP0005167_abnormal_blood-brain_barrier | 0.27609842 |
| 129 | MP0003959_abnormal_lean_body | 0.25698698 |
| 130 | MP0002132_abnormal_respiratory_system | 0.25611261 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.93912066 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.42592248 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.20871919 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.96898840 |
| 5 | Xanthomatosis (HP:0000991) | 5.66817759 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.57297489 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.41604108 |
| 8 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.75992324 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.73606089 |
| 10 | Hyperglycinuria (HP:0003108) | 4.63285313 |
| 11 | Hyperammonemia (HP:0001987) | 4.59064767 |
| 12 | Ketosis (HP:0001946) | 4.51840830 |
| 13 | Hyperglycinemia (HP:0002154) | 4.49611163 |
| 14 | Complement deficiency (HP:0004431) | 4.40456000 |
| 15 | Abnormality of glycine metabolism (HP:0010895) | 4.37615694 |
| 16 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.37615694 |
| 17 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.23968634 |
| 18 | Joint hemorrhage (HP:0005261) | 4.21417423 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.13227032 |
| 20 | Hypolipoproteinemia (HP:0010981) | 4.04815746 |
| 21 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.81676145 |
| 22 | Hypoglycemic coma (HP:0001325) | 3.79051676 |
| 23 | Gout (HP:0001997) | 3.77756408 |
| 24 | Fat malabsorption (HP:0002630) | 3.77299321 |
| 25 | Abnormality of the common coagulation pathway (HP:0010990) | 3.75316078 |
| 26 | Abnormality of methionine metabolism (HP:0010901) | 3.68913530 |
| 27 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.68259684 |
| 28 | Epidermoid cyst (HP:0200040) | 3.67666318 |
| 29 | Ketoacidosis (HP:0001993) | 3.59417399 |
| 30 | Widely patent fontanelles and sutures (HP:0004492) | 3.55663137 |
| 31 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.51964504 |
| 32 | Abnormality of nucleobase metabolism (HP:0010932) | 3.50059858 |
| 33 | Abnormality of purine metabolism (HP:0004352) | 3.49107535 |
| 34 | Hypoalphalipoproteinemia (HP:0003233) | 3.42004438 |
| 35 | Conjugated hyperbilirubinemia (HP:0002908) | 3.35356418 |
| 36 | Delayed CNS myelination (HP:0002188) | 3.33679522 |
| 37 | Abnormality of vitamin metabolism (HP:0100508) | 3.33111283 |
| 38 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.32273235 |
| 39 | Confusion (HP:0001289) | 3.29610899 |
| 40 | Hemorrhage of the eye (HP:0011885) | 3.28567848 |
| 41 | Abnormality of the intrinsic pathway (HP:0010989) | 3.23170065 |
| 42 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.22846186 |
| 43 | Hyperbilirubinemia (HP:0002904) | 3.21418397 |
| 44 | Abnormality of complement system (HP:0005339) | 3.20776048 |
| 45 | Ileus (HP:0002595) | 3.11129625 |
| 46 | Hypercholesterolemia (HP:0003124) | 3.08031167 |
| 47 | Metabolic acidosis (HP:0001942) | 3.07886041 |
| 48 | Abnormality of serum amino acid levels (HP:0003112) | 3.03411898 |
| 49 | Dicarboxylic aciduria (HP:0003215) | 3.02786468 |
| 50 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.02786468 |
| 51 | Abnormality of vitamin B metabolism (HP:0004340) | 3.01668715 |
| 52 | Generalized aminoaciduria (HP:0002909) | 2.93569058 |
| 53 | Proximal tubulopathy (HP:0000114) | 2.87936101 |
| 54 | Nephritis (HP:0000123) | 2.85723321 |
| 55 | Megaloblastic anemia (HP:0001889) | 2.83779881 |
| 56 | Facial shape deformation (HP:0011334) | 2.83766598 |
| 57 | Potter facies (HP:0002009) | 2.83766598 |
| 58 | Lethargy (HP:0001254) | 2.83471869 |
| 59 | Hepatocellular carcinoma (HP:0001402) | 2.83375352 |
| 60 | Steatorrhea (HP:0002570) | 2.82555301 |
| 61 | Abnormal urine phosphate concentration (HP:0012599) | 2.82537044 |
| 62 | Alkalosis (HP:0001948) | 2.74944289 |
| 63 | Vascular calcification (HP:0004934) | 2.74889483 |
| 64 | Increased purine levels (HP:0004368) | 2.74758173 |
| 65 | Hyperuricemia (HP:0002149) | 2.74758173 |
| 66 | Malnutrition (HP:0004395) | 2.68552401 |
| 67 | Hypophosphatemia (HP:0002148) | 2.65281703 |
| 68 | Wide cranial sutures (HP:0010537) | 2.64589521 |
| 69 | Systemic lupus erythematosus (HP:0002725) | 2.58552907 |
| 70 | Pigmentary retinal degeneration (HP:0001146) | 2.57124910 |
| 71 | Chronic diarrhea (HP:0002028) | 2.53750661 |
| 72 | Glycosuria (HP:0003076) | 2.50023407 |
| 73 | Abnormality of urine glucose concentration (HP:0011016) | 2.50023407 |
| 74 | Spontaneous abortion (HP:0005268) | 2.49734397 |
| 75 | Cerebral edema (HP:0002181) | 2.49574821 |
| 76 | Vomiting (HP:0002013) | 2.45098538 |
| 77 | Irritability (HP:0000737) | 2.41141687 |
| 78 | Spastic diplegia (HP:0001264) | 2.41110311 |
| 79 | Cardiovascular calcification (HP:0011915) | 2.40949174 |
| 80 | Late onset (HP:0003584) | 2.40896115 |
| 81 | Neonatal onset (HP:0003623) | 2.38943271 |
| 82 | Myocardial infarction (HP:0001658) | 2.38152154 |
| 83 | Abnormality of proline metabolism (HP:0010907) | 2.34904714 |
| 84 | Hydroxyprolinuria (HP:0003080) | 2.34904714 |
| 85 | Enlarged kidneys (HP:0000105) | 2.31905195 |
| 86 | Hypochromic microcytic anemia (HP:0004840) | 2.31419217 |
| 87 | Hypoglycemic seizures (HP:0002173) | 2.29766882 |
| 88 | Pancreatitis (HP:0001733) | 2.22651403 |
| 89 | Abnormal gallbladder physiology (HP:0012438) | 2.22596266 |
| 90 | Cholecystitis (HP:0001082) | 2.22596266 |
| 91 | Acanthocytosis (HP:0001927) | 2.22058313 |
| 92 | Sensorimotor neuropathy (HP:0007141) | 2.20840914 |
| 93 | Purpura (HP:0000979) | 2.18342027 |
| 94 | Rickets (HP:0002748) | 2.17256076 |
| 95 | Skin nodule (HP:0200036) | 2.17101122 |
| 96 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.13438656 |
| 97 | Glomerulonephritis (HP:0000099) | 2.12286395 |
| 98 | Abnormal gallbladder morphology (HP:0012437) | 2.11695880 |
| 99 | Cerebral palsy (HP:0100021) | 2.11078844 |
| 100 | Abdominal distention (HP:0003270) | 2.09796891 |
| 101 | Cholelithiasis (HP:0001081) | 2.08921117 |
| 102 | Thin bony cortex (HP:0002753) | 2.08673864 |
| 103 | Mitral stenosis (HP:0001718) | 2.07645458 |
| 104 | Menorrhagia (HP:0000132) | 2.06063395 |
| 105 | Brushfield spots (HP:0001088) | 2.04051586 |
| 106 | Osteomalacia (HP:0002749) | 2.03419737 |
| 107 | Poikilocytosis (HP:0004447) | 2.03227487 |
| 108 | Opisthotonus (HP:0002179) | 2.03173492 |
| 109 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.03149855 |
| 110 | Hypotension (HP:0002615) | 2.02014658 |
| 111 | Elevated alkaline phosphatase (HP:0003155) | 2.01441781 |
| 112 | Focal segmental glomerulosclerosis (HP:0000097) | 2.00745382 |
| 113 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.99693326 |
| 114 | Esophageal varix (HP:0002040) | 1.97977488 |
| 115 | Nausea (HP:0002018) | 1.95472065 |
| 116 | Amyloidosis (HP:0011034) | 1.94510127 |
| 117 | Nephrolithiasis (HP:0000787) | 1.93402257 |
| 118 | Gingival bleeding (HP:0000225) | 1.92295372 |
| 119 | Abnormal cartilage morphology (HP:0002763) | 1.90424585 |
| 120 | Hyperphosphaturia (HP:0003109) | 1.90393075 |
| 121 | Thrombophlebitis (HP:0004418) | 1.89597416 |
| 122 | Hypokalemic alkalosis (HP:0001949) | 1.86484660 |
| 123 | Renal cortical cysts (HP:0000803) | 1.83463747 |
| 124 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.81479156 |
| 125 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.81333628 |
| 126 | Hypophosphatemic rickets (HP:0004912) | 1.80911303 |
| 127 | Delayed epiphyseal ossification (HP:0002663) | 1.80420841 |
| 128 | Renal tubular dysfunction (HP:0000124) | 1.78678727 |
| 129 | Glomerulosclerosis (HP:0000096) | 1.71196431 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.29152996 |
| 2 | ACVR1B | 5.82047554 |
| 3 | ERN1 | 4.48254600 |
| 4 | FGFR4 | 4.04502509 |
| 5 | SIK1 | 3.75783899 |
| 6 | TAOK3 | 2.76093589 |
| 7 | WNK3 | 2.64151218 |
| 8 | WNK4 | 2.49654270 |
| 9 | EPHA2 | 2.46683806 |
| 10 | TESK2 | 2.45062019 |
| 11 | INSRR | 2.39838346 |
| 12 | MST1R | 2.36332054 |
| 13 | PKN2 | 2.29627548 |
| 14 | OXSR1 | 2.09864975 |
| 15 | ERBB4 | 2.00893010 |
| 16 | FLT3 | 1.98181253 |
| 17 | EPHA4 | 1.92582160 |
| 18 | SMG1 | 1.74896091 |
| 19 | MAP2K4 | 1.72497456 |
| 20 | TRIB3 | 1.72240843 |
| 21 | MAPK11 | 1.72212742 |
| 22 | TYK2 | 1.67089105 |
| 23 | PIK3CG | 1.61064016 |
| 24 | PRPF4B | 1.60496503 |
| 25 | MAP3K2 | 1.60035263 |
| 26 | GRK6 | 1.42019236 |
| 27 | NEK9 | 1.40828869 |
| 28 | ABL2 | 1.39254881 |
| 29 | MAP2K3 | 1.36233987 |
| 30 | PTK6 | 1.31691364 |
| 31 | PINK1 | 1.29973783 |
| 32 | FRK | 1.29261724 |
| 33 | STK38L | 1.27316625 |
| 34 | KDR | 1.25004021 |
| 35 | TBK1 | 1.23494241 |
| 36 | MAP3K7 | 1.20480779 |
| 37 | ICK | 1.19264789 |
| 38 | MAP3K3 | 1.15340107 |
| 39 | JAK2 | 1.11197414 |
| 40 | TESK1 | 1.09995729 |
| 41 | TIE1 | 1.08496164 |
| 42 | PRKAA2 | 1.04803800 |
| 43 | MAP3K12 | 1.03495853 |
| 44 | TGFBR2 | 1.02941145 |
| 45 | MAP3K11 | 1.01959649 |
| 46 | RIPK4 | 0.99177771 |
| 47 | MAPK15 | 0.98019511 |
| 48 | DDR2 | 0.96591797 |
| 49 | MAP2K6 | 0.96132349 |
| 50 | DAPK2 | 0.95393057 |
| 51 | MAP3K14 | 0.94202265 |
| 52 | MATK | 0.93607277 |
| 53 | EPHB1 | 0.93105586 |
| 54 | PIK3CA | 0.92103174 |
| 55 | NEK1 | 0.89779223 |
| 56 | MAPK4 | 0.89525863 |
| 57 | LATS1 | 0.89368742 |
| 58 | IRAK3 | 0.89125132 |
| 59 | TNIK | 0.85683557 |
| 60 | DYRK1B | 0.79960652 |
| 61 | JAK1 | 0.78654346 |
| 62 | KSR2 | 0.76618284 |
| 63 | DAPK1 | 0.74649378 |
| 64 | PRKCZ | 0.73611634 |
| 65 | GSK3A | 0.72660133 |
| 66 | RIPK1 | 0.71484026 |
| 67 | MAP4K1 | 0.69572811 |
| 68 | SGK494 | 0.69337175 |
| 69 | SGK223 | 0.69337175 |
| 70 | IKBKE | 0.68816158 |
| 71 | PIM2 | 0.68368417 |
| 72 | MAP3K10 | 0.67530319 |
| 73 | CSK | 0.67333105 |
| 74 | PDK3 | 0.67086713 |
| 75 | PDK4 | 0.67086713 |
| 76 | PRKACG | 0.66960221 |
| 77 | SGK3 | 0.66378987 |
| 78 | ERBB2 | 0.64276452 |
| 79 | MAPK12 | 0.63240639 |
| 80 | NME1 | 0.63112015 |
| 81 | TAOK1 | 0.62861935 |
| 82 | NME2 | 0.62151206 |
| 83 | MET | 0.61771252 |
| 84 | PRKAA1 | 0.61652699 |
| 85 | RET | 0.61545569 |
| 86 | CDK6 | 0.60889808 |
| 87 | CSF1R | 0.60008200 |
| 88 | EPHB2 | 0.59296671 |
| 89 | STK16 | 0.58754737 |
| 90 | PDPK1 | 0.58192317 |
| 91 | CDC42BPA | 0.56821094 |
| 92 | PTK2 | 0.55742534 |
| 93 | SGK2 | 0.55675742 |
| 94 | KIT | 0.53090420 |
| 95 | EEF2K | 0.51665080 |
| 96 | FGFR2 | 0.50899742 |
| 97 | AKT3 | 0.49373019 |
| 98 | LRRK2 | 0.49173148 |
| 99 | CAMK1D | 0.48932585 |
| 100 | CAMK2G | 0.47897565 |
| 101 | MAP2K2 | 0.47860392 |
| 102 | SRC | 0.47027491 |
| 103 | STK39 | 0.46053036 |
| 104 | SCYL2 | 0.45657815 |
| 105 | PAK4 | 0.43518915 |
| 106 | PDK1 | 0.42858831 |
| 107 | EPHA3 | 0.42378755 |
| 108 | CAMK2B | 0.42169353 |
| 109 | PDK2 | 0.40970485 |
| 110 | MAP3K8 | 0.40730694 |
| 111 | BTK | 0.40074146 |
| 112 | CAMK2D | 0.39598692 |
| 113 | TAOK2 | 0.38027595 |
| 114 | MAP3K5 | 0.37505505 |
| 115 | PRKCQ | 0.37087326 |
| 116 | PDGFRA | 0.36661497 |
| 117 | MAP3K6 | 0.36309652 |
| 118 | ZAP70 | 0.35452531 |
| 119 | MYLK | 0.35415382 |
| 120 | GRK1 | 0.35111859 |
| 121 | STK24 | 0.33783010 |
| 122 | FER | 0.33760583 |
| 123 | IGF1R | 0.33377234 |
| 124 | BLK | 0.33296201 |
| 125 | PRKACA | 0.32778870 |
| 126 | CDK7 | 0.32726922 |
| 127 | ARAF | 0.31659020 |
| 128 | PRKG2 | 0.30273305 |
| 129 | LMTK2 | 0.29368111 |
| 130 | CAMK4 | 0.29217712 |
| 131 | CDK4 | 0.28486999 |
| 132 | PIM1 | 0.28383709 |
| 133 | CSNK1G1 | 0.28233764 |
| 134 | CSNK2A1 | 0.27961762 |
| 135 | PRKCI | 0.26652025 |
| 136 | FYN | 0.26065196 |
| 137 | MAP3K1 | 0.25467123 |
| 138 | FGFR3 | 0.25289958 |
| 139 | PRKCA | 0.24946206 |
| 140 | MAP2K1 | 0.24927309 |
| 141 | IRAK1 | 0.24725531 |
| 142 | NLK | 0.24511950 |
| 143 | CSNK1A1 | 0.23886237 |
| 144 | PRKCD | 0.23712339 |
| 145 | CSNK2A2 | 0.23458605 |
| 146 | MST4 | 0.23161925 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.09844013 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.51174102 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.05769192 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.03969856 |
| 5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.80709693 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.79732368 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.69372169 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.62855004 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.62472117 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.55613325 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.50672216 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.47566624 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.38672487 |
| 14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.33283393 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.23124370 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.16194648 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.09074869 |
| 18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.94535331 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.87816057 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.85921146 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.85445959 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.84527866 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.82810494 |
| 24 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.81849735 |
| 25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.79284902 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.78554031 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.74492908 |
| 28 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.64886048 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.61686707 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.60208861 |
| 31 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.58348181 |
| 32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.57893030 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.55793383 |
| 34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.55363154 |
| 35 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.52972829 |
| 36 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.52161751 |
| 37 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.47596684 |
| 38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.44347404 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.39514629 |
| 40 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.38616497 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.34338821 |
| 42 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.32647448 |
| 43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.28486961 |
| 44 | Carbon metabolism_Homo sapiens_hsa01200 | 1.28481196 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.26373243 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.22280057 |
| 47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.21396867 |
| 48 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.17122606 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.15878355 |
| 50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.14098264 |
| 51 | ABC transporters_Homo sapiens_hsa02010 | 1.09543105 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.08626219 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.05798550 |
| 54 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.00510625 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.98734437 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.97784168 |
| 57 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.92294441 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89570903 |
| 59 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.86814129 |
| 60 | Lysine degradation_Homo sapiens_hsa00310 | 0.86514617 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.83692147 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.76156136 |
| 63 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.70422243 |
| 64 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.68307246 |
| 65 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.67612244 |
| 66 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.53048232 |
| 67 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.52872972 |
| 68 | Galactose metabolism_Homo sapiens_hsa00052 | 0.39744495 |
| 69 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.34803829 |
| 70 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.32911802 |
| 71 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.25379701 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24840639 |
| 73 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.24256091 |
| 74 | * Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22983332 |
| 75 | Pertussis_Homo sapiens_hsa05133 | 0.19154423 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.18743191 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.17781947 |
| 78 | Prion diseases_Homo sapiens_hsa05020 | 0.16589412 |
| 79 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.14669730 |
| 80 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.14497167 |
| 81 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.10948661 |
| 82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.10354783 |
| 83 | Asthma_Homo sapiens_hsa05310 | 0.06043618 |
| 84 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.05057871 |
| 85 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.03002172 |
| 86 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.02243422 |
| 87 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.2198695 |
| 88 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2007339 |
| 89 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1944284 |
| 90 | Parkinsons disease_Homo sapiens_hsa05012 | -0.1935289 |
| 91 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1591982 |
| 92 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1460033 |
| 93 | Hepatitis C_Homo sapiens_hsa05160 | -0.1456346 |
| 94 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | -0.1415899 |
| 95 | Lysosome_Homo sapiens_hsa04142 | -0.1411085 |
| 96 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1401157 |
| 97 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | -0.1350489 |
| 98 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.1255344 |
| 99 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1244602 |
| 100 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.1159400 |
| 101 | Allograft rejection_Homo sapiens_hsa05330 | -0.1108895 |
| 102 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1103891 |
| 103 | Cocaine addiction_Homo sapiens_hsa05030 | -0.0792266 |
| 104 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0738460 |
| 105 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.0699029 |
| 106 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.0679028 |
| 107 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0662307 |
| 108 | Mineral absorption_Homo sapiens_hsa04978 | -0.0606735 |
| 109 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0376403 |
| 110 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0352153 |
| 111 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.0344451 |
| 112 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0262963 |
| 113 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0231390 |
| 114 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0153802 |

